Status:

COMPLETED

Vaginal Transluminal Endoscopic Sacrocolpopexy

Lead Sponsor:

Dr. Lutfi Kirdar Kartal Training and Research Hospital

Conditions:

Pelvic Organ Prolapse

Eligibility:

FEMALE

45-79 years

Phase:

NA

Brief Summary

This study aims to evaluate the outcomes of V-NOTES sacrocolpopexy following vaginal hysterectomy, focusing on perioperative and early postoperative results. The impact of V-NOTES sacrocolpopexy on pa...

Detailed Description

Patients who presented to the obstetrics and gynecology outpatient clinic with complaints related to pelvic organ prolapse, had stage III or IV prolapse according to POP-Q classification, were between...

Eligibility Criteria

Inclusion

  • Patients who presented to the obstetrics and gynecology outpatient clinic with complaints related to pelvic organ prolapse, had stage III or IV prolapse according to POP-Q classification, were between 45 and 79 years old, had no contraindications for pneumoperitoneum and Trendelenburg position, and were eligible to perform transvaginal NOTES were included in the study.

Exclusion

  • Patients with previous pelvic inflammatory disease, deep endometriosis, severe pelvic adhesions, and patients who are at risk of gynecological malignancy and are not suitable for transvaginal surgery were not included in the study.

Key Trial Info

Start Date :

October 1 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 1 2022

Estimated Enrollment :

11 Patients enrolled

Trial Details

Trial ID

NCT06004089

Start Date

October 1 2021

End Date

May 1 2022

Last Update

August 22 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Kartal Dr. Lutfi Kirdar City Hospital

Istanbul, Kartal, Turkey (Türkiye)